Molly Mandernach

CLIN PROF

MD-MEDICINE

sort by:

GRANT
CTOA
University of Florida4 May 2022 - 11 Aug 2026
Closed
GRANT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
National Center for Complem and Integrative Hlt22 Dec 2021 - 31 Aug 2025
Expired
GRANT
A Phase II, multicenter, randomized, open label two arm study comparing the effect of crizanlizumab + standard of care to standard of care alone on renal function in sickle cell disease patients = 16 years with chronic kidney disease due to sickle cell nephropathy (STEADFAST)
Novartis Pharmaceuticals Corporation15 Sep 2021 - 31 Aug 2022
Closed
GRANT
Education and Mentoring to Bring Access to Comprehensive Care (EMBRACE) Network
US Health Resources and Serv Administration1 Sep 2021 - 31 Aug 2026
Active
GRANT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
National Institute of Health Ninds25 Nov 2020 - 31 Aug 2021
Expired
GRANT
A Stress and Pain Self-management m-Health App for Adult Outpatients with Sickle Cell Disease
National Institute of Health Ninr7 Sep 2020 - 30 Jun 2026
Expired
GRANT
A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease
Global Blood Therapeutics27 Sep 2017 - 6 Jul 2022
Closed

GRANTS